Identification of Class I HLA T Cell Control Epitopes for West Nile Virus

PLoS ONE

Volumn 8, Issue 6, 2013, Pages

  Kaabinejadian, Saghar ^a   Piazza, Paolo A ^b   McMurtrey, Curtis P ^a   Vernon, Stephen R ^a   Cate, Steven J ^a   Bardet, Wilfried ^a   Schafer, Fredda B ^a   Jackson, Kenneth W ^a   Campbell, Diana M ^b   Buchli, Rico ^d   Rinaldo, Charles R ^c   Hildebrand, William H ^a,d  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^d Pure Protein LLC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; HLA ANTIGEN CLASS 1; NONSTRUCTURAL PROTEIN 3; NONSTRUCTURAL PROTEIN 4B; NONSTRUCTURAL PROTEIN 5; PEPTIDE;

ADULT; AGED; ANTIGEN PRESENTATION; ANTIGEN RECOGNITION; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOGENICITY; MAJOR CLINICAL STUDY; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; T LYMPHOCYTE; VIRUS CAPSID; WEST NILE FEVER; WEST NILE FLAVIVIRUS;

ADULT; AGED; BLOTTING, WESTERN; CELLS, CULTURED; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; EPITOPES, T-LYMPHOCYTE; FEMALE; FLOW CYTOMETRY; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; MALE; MIDDLE AGED; PEPTIDE FRAGMENTS; REAL-TIME POLYMERASE CHAIN REACTION; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; WEST NILE FEVER; WEST NILE VIRUS; YOUNG ADULT;

MIRIDAE; WEST NILE VIRUS;

EID: 84878882535     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0066298     Document Type: Article

References (46)

1. De Filette M, Ulbert S, Diamond M, Sanders NN, (2012) Recent progress in West Nile virus diagnosis and vaccination. Vet Res 43: 16.
2. The CDC website. Available: http://www.cdc.gov/ncidod/dvbid/westnile/surv&control. htm. Accessed 2012 Dec 11.
3. Brown CM, Demaria A (2012) The Resurgence of West Nile Virus. Ann Intern Med doi: 10.7326/0003-4819-157-11-201212040-00543.
4. Mostashari F, Bunning ML, Kitsutani PT, Singer DA, Nash D, et al. (2001) Epidemic West Nile encephalitis, New York, 1999: results of a household-based seroepidemiological survey. Lancet 358: 261-264.
5. Custer B, Kamel H, Kiely NE, Murphy EL, Busch MP, (2009) Associations between West Nile virus infection and symptoms reported by blood donors identified through nucleic acid test screening. Transfusion 49: 278-288.
6. Rodriguez Mde L, Rodriguez DR, Blitvich BJ, Lopez MA, Fernandez-Salas I, et al. (2010) Serologic surveillance for West Nile virus and other flaviviruses in febrile patients, encephalitic patients, and asymptomatic blood donors in northern Mexico. Vector Borne Zoonotic Dis 10: 151-157.
7. Diamond MS, Pierson TC, Fremont DH, (2008) The structural immunology of antibody protection against West Nile virus. Immunol Rev 225: 212-225.
8. Martina BEE, van den Doel P, Koraka P, van Amerongen G, Spohn G, et al. (2011) A recombinant Influenza A virus expressing domain III of West Nile virus induces protective immune responses against Influenza and West Nile virus. PLoS ONE 6: e18995.
9. Shrestha B, Diamond MS, (2004) Role of CD8+ T cells in control of West Nile virus infection. J Virol 78: 8312-8321.
10. Wang Y, Lobigs M, Lee E, Mullbacher A, (2003) CD8+ T cells mediate recovery and immunopathology in West Nile virus encephalitis. J Virol 77: 13323-13334.
11. Glass WG, McDermott DH, Lim JK, Lekhong S, Yu SF, et al. (2006) CCR5 deficiency increases risk of symptomatic West Nile virus infection. J Exp Med 203: 35-40.
12. Larsen MV, Lelic A, Parsons R, Nielsen M, Hoof I, et al. (2010) Identification of CD8+ T cell epitopes in the West Nile virus polyprotein by reverse-immunology using NetCTL. PLoS One 5: e12697.
13. McMurtrey CP, Lelic A, Piazza P, Chakrabarti AK, Yablonsky EJ, et al. (2008) Epitope discovery in West Nile virus infection: Identification and immune recognition of viral epitopes. Proc Natl Acad Sci U S A 105: 2981-2986.
14. Kim S, Li L, McMurtrey CP, Hildebrand WH, Weidanz JA, et al. (2010) Single-chain HLA-A2 MHC trimers that incorporate an immundominant peptide elicit protective T cell immunity against lethal West Nile virus infection. J Immunol 184: 4423-4430.
15. Smith HL, Monath TP, Pazoles P, Rothman AL, Casey DM, et al. (2011) Development of antigen-specific memory CD8+ T cells following live-attenuated chimeric West Nile virus vaccination. J Infect Dis 203: 513-522.
16. Wahl A, Weidanz J, Hildebrand W, (2006) Direct class I HLA antigen discovery to distinguish virus-infected and cancerous cells. Expert Rev Proteomics 3: 641-652.
17. Hickman HD, Luis AD, Buchli R, Few SR, Sathiamurthy M, et al. (2004) Toward a definition of self: Proteomic evaluation of the class I peptide repertoire. J Immunol 172: 2944-2952.
18. Bell EB, Westermann J, (2008) CD4 memory T cells on trial: immunological memory without a memory T cell. Trends Immunol 29: 405-411.
19. Eneslatt K, Normark M, Bjork R, Rietz C, Zingmark C, et al. (2012) Signatures of T cells as correlates of immunity to Francisella tularensis. PLoS One 7: e32367.
20. Caccamo N, Guggino G, Joosten SA, Gelsomino G, Di Carlo P, et al. (2010) Multifunctional CD4(+) T cells correlate with active Mycobacterium tuberculosis infection. Eur J Immunol 40: 2211-2220.
21. Jackson HM, Dimopoulos N, Chen Q, Luke T, Yee Tai T, et al. (2004) A robust human T-cell culture method suitable for monitoring CD8+ and CD4+ T-cell responses from cancer clinical trial samples. J Immunol Methods 291: 51-62.
22. Lin Y, Gallardo HF, Ku GY, Li H, Manukian G, et al. (2009) Optimization and validation of a robust human T cell culture method for monitoring phenotypic and polyfunctional antigen specific CD4 and CD8 T-cell responses. Cytotherapy 11: 912-922.
23. Weiskopf D, Yauch LE, Angelo MA, John DV, Greenbaum JA, et al. (2011) Insights into HLA-Restricted T Cell Responses in a Novel Mouse Model of Dengue Virus Infection Point toward New Implications for Vaccine Design. Journal of Immunology 187: 4268-4279.
24. Tan AC, La Gruta NL, Zeng W, Jackson DC, (2011) Precursor frequency and competition dictate the HLA-A2-restricted CD8+ T cell responses to influenza A infection and vaccination in HLA-A2.1 transgenic mice. J Immunol 187: 1895-1902.
25. Harari A, Dutoit V, Cellerai C, Bart PA, Du Pasquier RA, et al. (2006) Functional signatures of protective antiviral T-cell immunity in human virus infections. Immunol Rev 211: 236-254.
26. Duvall MG, Precopio ML, Ambrozak DA, Jaye A, McMichael AJ, et al. (2008) Polyfunctional T cell responses are a hallmark of HIV-2 infection. Eur J Immunol 38: 350-363.
27. Akondy RS, Monson ND, Miller JD, Edupuganti S, Teuwen D, et al. (2009) The yellow fever virus vaccine induces a broad and polyfunctional human memory CD8+ T cell response. J Immunol 183: 7919-7930.
28. Oliphant T, Nybakken GE, Austin SK, Xu Q, Bramson J, et al. (2007) Induction of epitope-specific neutralizing antibodies against West Nile virus. J Virol 81: 11828-11839.
29. Diamond MS, Shrestha B, Marri A, Mahan D, Engle M, (2003) B cells and antibody play critical roles in the immediate defense of disseminated infection by West Nile encephalitis virus. J Virol 77: 2578-2586.
30. Diamond MS, Sitati EM, Friend LD, Higgs S, Shrestha B, et al. (2003) A critical role for induced IgM in the protection against West Nile virus infection. J Exp Med 198: 1853-1862.
31. Haynes BF, Kelsoe G, Harrison SC, Kepler TB, (2012) B-cell-lineage immunogen design in vaccine development with HIV-1 as a case study. Nat Biotechnol 30: 423-433.
32. Busch MP, Kleinman SH, Tobler LH, Kamel HT, Norris PJ, et al. (2008) Virus and antibody dynamics in acute west nile virus infection. J Infect Dis 198: 984-993.
33. Kloetzel PM, Ossendorp F, (2004) Proteasome and peptidase function in MHC-class-I-mediated antigen presentation. Curr Opin Immunol 16: 76-81.
34. Seifert U, Maranon C, Shmueli A, Desoutter JF, Wesoloski L, et al. (2003) An essential role for tripeptidyl peptidase in the generation of an MHC class I epitope. Nat Immunol 4: 375-379.
35. Braun BC, Glickman M, Kraft R, Dahlmann B, Kloetzel PM, et al. (1999) The base of the proteasome regulatory particle exhibits chaperone-like activity. Nat Cell Biol 1: 221-226.
36. Roelse J, Gromme M, Momburg F, Hammerling G, Neefjes J, (1994) Trimming of TAP-translocated peptides in the endoplasmic reticulum and in the cytosol during recycling. J Exp Med 180: 1591-1597.
37. Wearsch PA, Jakob CA, Vallin A, Dwek RA, Rudd PM, et al. (2004) Major histocompatibility complex class I molecules expressed with monoglucosylated N-linked glycans bind calreticulin independently of their assembly status. J Biol Chem 279: 25112-25121.
38. Leach MR, Cohen-Doyle MF, Thomas DY, Williams DB, (2002) Localization of the lectin, ERp57 binding, and polypeptide binding sites of calnexin and calreticulin. J Biol Chem 277: 29686-29697.
39. Robinson HL, Amara RR, (2005) T cell vaccines for microbial infections. Nat Med 11: S25-S32.
40. Sette A, Fikes J, (2003) Epitope-based vaccines: an update on epitope identification, vaccine design and delivery. Curr Opin Immunol 15: 461-470.
41. Yewdell JW, (2007) Plumbing the sources of endogenous MHC class I peptide ligands. Curr Opin Immunol 19: 79-86.
42. Piazza P, McMurtrey CP, Lelic A, Cook RL, Hess R, et al. (2010) Surface phenotype and functionality of WNV specific T cells differ with age and disease severity. PLoS One 5: e15343.
43. Prilliman K, Lindsey M, Zuo Y, Jackson KW, Zhang Y, et al. (1997) Large-scale production of class I bound peptides: assigning a signature to HLA-B*1501. Immunogenetics 45: 379-385.
44. Prilliman KR, Jackson KW, Lindsey M, Wang JH, Crawford D, et al. (1999) HLA-B15 peptide ligands are preferentially anchored at their C termini. J Immunol 162: 7277-7284.
45. Buchli R, VanGundy RS, Hickman-Miller HD, Giberson CF, Bardet W, et al. (2005) Development and validation of a fluorescence polarization-based competitive peptide-binding assay for HLA-A*0201: A new tool for epitope discovery. Biochemistry 44: 12491-12507.
46. Leffell MS, Cherikh WS, Land G, Zachary AA, (2007) Improved definition of human leukocyte antigen frequencies among minorities and applicability to estimates of transplant compatibility. Transplantation 83: 964-972.